Global Biosimilars/Follow-on-Biologics Market By Product Type (Human Growth Hormone, Erythropoietin) And By End-Users/Application (Blood Disorders, Oncology Diseases) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-958020
  • March 2021
  • Healthcare
  • 135 Pages
The Biosimilars/Follow-on-Biologics market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Biosimilars/Follow-on-Biologics market research report recommends a business strategy for present market participants to strengthen their position in the market.

According to the report, the Biosimilars/Follow-on-Biologics market size was USD xx million and it is expected to reach USD xx million by the end of 2028, with a CAGR of xx% during 2020-2028. While considering the volume shipments the global Biosimilars/Follow-on-Biologics market stood at xx (Units/Tons) in 2020 and expected to cross near about xx (units/Tons) by the end of forecast period.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Biosimilars/Follow-on-Biologics market along with their effects over the forecast period. Similarly, according to the region Biosimilars/Follow-on-Biologics market research report includes the study of opportunities available in the market situation.

The Biosimilars/Follow-on-Biologics market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Peptide, Others
Applications Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases, Growth Hormone Deficiencies, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Novartis, Genentech (Roche Group), Synthon Pharmaceuticals, LG Life Sciences, Celltrion, Teva Pharmaceutical Industries, Merck Group, Biocon, Biogen idec, Inc., Hospira

Global Biosimilars/Follow-on-Biologics Market Segmentation by Regions:
In regional analysis, Biosimilars/Follow-on-Biologics market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Biosimilars/Follow-on-Biologics market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Biosimilars/Follow-on-Biologics Market: Value and Forecast
  • U.S.
  • Canada
 
Europe Region for Biosimilars/Follow-on-Biologics Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 
Asia Pacific Region for Biosimilars/Follow-on-Biologics Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 
Latin America Region for Biosimilars/Follow-on-Biologics Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 
Middle East and Africa for Biosimilars/Follow-on-Biologics Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Global Biosimilars/Follow-on-Biologics Market Segmentation by Type:
On the basis of product type, global Biosimilars/Follow-on-Biologics market research report provides the production, revenue, price, and market share and growth rate of each type, primarily split into: Human Growth Hormone, Erythropoietin, Monoclonal Antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Peptide, Others

Global Biosimilars/Follow-on-Biologics Market Segmentation by Applications:
On the basis of the end users/applications, Biosimilars/Follow-on-Biologics research report analyze the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including: Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases, Growth Hormone Deficiencies, Others

Major Key Players for Global Biosimilars/Follow-on-Biologics Market:
The Biosimilars/Follow-on-Biologics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Novartis, Genentech (Roche Group), Synthon Pharmaceuticals, LG Life Sciences, Celltrion, Teva Pharmaceutical Industries, Merck Group, Biocon, Biogen idec, Inc., Hospira

Important Points Covered by Report:
  • To analyze the value of the Biosimilars/Follow-on-Biologics market, according to the key region.
  • To study the Biosimilars/Follow-on-Biologics market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Biosimilars/Follow-on-Biologics market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Biosimilars/Follow-on-Biologics research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Biosimilars/Follow-on-Biologics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Biosimilars/Follow-on-Biologics market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Biosimilars/Follow-on-Biologics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Biosimilars/Follow-on-Biologics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Biosimilars/Follow-on-Biologics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Biosimilars/Follow-on-Biologics Market Snapshot
          2.1.1. Global Biosimilars/Follow-on-Biologics Market By Type,2019
               2.1.1.1.Human Growth Hormone
               2.1.1.2.Erythropoietin
               2.1.1.3.Monoclonal Antibodies
               2.1.1.4.Insulin
               2.1.1.5.Interferon
               2.1.1.6.Granulocyte-Colony Stimulating Factor
               2.1.1.7.Peptide
               2.1.1.8.Others
          2.1.2. Global Biosimilars/Follow-on-Biologics Market By Application,2019
               2.1.2.1.Blood Disorders
               2.1.2.2.Oncology Diseases
               2.1.2.3.Chronic and Autoimmune Diseases
               2.1.2.4.Growth Hormone Deficiencies
               2.1.2.5.Others
          2.1.3. Global Biosimilars/Follow-on-Biologics Market By End-use,2019
          2.1.4. Global Biosimilars/Follow-on-Biologics Market By Geography,2019

3. Global Biosimilars/Follow-on-Biologics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Biosimilars/Follow-on-Biologics Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Biosimilars/Follow-on-Biologics Market Size (US$), By Type, 2018 – 2028

5. Global Biosimilars/Follow-on-Biologics Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Biosimilars/Follow-on-Biologics Market Size (US$), By Application, 2018 – 2028

6. Global Biosimilars/Follow-on-Biologics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Biosimilars/Follow-on-Biologics Market Size (US$), By End-use, 2018 – 2028

7. Global Biosimilars/Follow-on-Biologics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Biosimilars/Follow-on-Biologics Market Analysis, 2018 – 2028 
          7.2.1. North America Biosimilars/Follow-on-Biologics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Biosimilars/Follow-on-Biologics Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Biosimilars/Follow-on-Biologics Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Biosimilars/Follow-on-Biologics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Biosimilars/Follow-on-Biologics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Biosimilars/Follow-on-Biologics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Biosimilars/Follow-on-Biologics Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Biosimilars/Follow-on-Biologics Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Biosimilars/Follow-on-Biologics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Biosimilars/Follow-on-Biologics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Biosimilars/Follow-on-Biologics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Biosimilars/Follow-on-Biologics Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Biosimilars/Follow-on-Biologics Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Biosimilars/Follow-on-Biologics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Biosimilars/Follow-on-Biologics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Biosimilars/Follow-on-Biologics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Biosimilars/Follow-on-Biologics Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Biosimilars/Follow-on-Biologics Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Biosimilars/Follow-on-Biologics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Biosimilars/Follow-on-Biologics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Biosimilars/Follow-on-Biologics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Biosimilars/Follow-on-Biologics Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Biosimilars/Follow-on-Biologics Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Biosimilars/Follow-on-Biologics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Biosimilars/Follow-on-Biologics Providers
        8.4.1 Novartis
                8.1.1 Business Description
                8.1.2 Novartis Geographic Operations
                8.1.3 Novartis Financial Information
                8.1.4 Novartis Product Positions/Portfolio
                8.1.5 Novartis Key Developments
        8.4.2 Genentech (Roche Group)
                8.2.1 Business Description
                8.2.2 Genentech (Roche Group) Geographic Operations
                8.2.3 Genentech (Roche Group) Financial Information
                8.2.4 Genentech (Roche Group) Product Positions/Portfolio
                8.2.5 Genentech (Roche Group) Key Developments
        8.4.3 Synthon Pharmaceuticals
                8.3.1 Business Description
                8.3.2 Synthon Pharmaceuticals Geographic Operations
                8.3.3 Synthon Pharmaceuticals Financial Information
                8.3.4 Synthon Pharmaceuticals Product Positions/Portfolio
                8.3.5 Synthon Pharmaceuticals Key Developments
        8.4.4 LG Life Sciences
                8.4.1 Business Description
                8.4.2 LG Life Sciences Geographic Operations
                8.4.3 LG Life Sciences Financial Information
                8.4.4 LG Life Sciences Product Positions/Portfolio
                8.4.5 LG Life Sciences Key Developments
        8.4.5 Celltrion
                8.5.1 Business Description
                8.5.2 Celltrion Geographic Operations
                8.5.3 Celltrion Financial Information
                8.5.4 Celltrion Product Positions/Portfolio
                8.5.5 Celltrion Key Developments
        8.4.6 Teva Pharmaceutical Industries
                8.6.1 Business Description
                8.6.2 Teva Pharmaceutical Industries Geographic Operations
                8.6.3 Teva Pharmaceutical Industries Financial Information
                8.6.4 Teva Pharmaceutical Industries Product Positions/Portfolio
                8.6.5 Teva Pharmaceutical Industries Key Developments
        8.4.7 Merck Group
                8.7.1 Business Description
                8.7.2 Merck Group Geographic Operations
                8.7.3 Merck Group Financial Information
                8.7.4 Merck Group Product Positions/Portfolio
                8.7.5 Merck Group Key Developments
        8.4.8 Biocon
                8.8.1 Business Description
                8.8.2 Biocon Geographic Operations
                8.8.3 Biocon Financial Information
                8.8.4 Biocon Product Positions/Portfolio
                8.8.5 Biocon Key Developments
        8.4.9 Biogen idec, Inc.
                8.9.1 Business Description
                8.9.2 Biogen idec, Inc. Geographic Operations
                8.9.3 Biogen idec, Inc. Financial Information
                8.9.4 Biogen idec, Inc. Product Positions/Portfolio
                8.9.5 Biogen idec, Inc. Key Developments
        8.4.10 Hospira
                8.10.1 Business Description
                8.10.2 Hospira Geographic Operations
                8.10.3 Hospira Financial Information
                8.10.4 Hospira Product Positions/Portfolio
                8.10.5 Hospira Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Biosimilars/Follow-on-Biologics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Biosimilars/Follow-on-Biologics Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Biosimilars/Follow-on-Biologics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Biosimilars/Follow-on-Biologics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Biosimilars/Follow-on-Biologics Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Biosimilars/Follow-on-Biologics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Biosimilars/Follow-on-Biologics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Biosimilars/Follow-on-Biologics Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Biosimilars/Follow-on-Biologics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Biosimilars/Follow-on-Biologics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Biosimilars/Follow-on-Biologics Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Biosimilars/Follow-on-Biologics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Biosimilars/Follow-on-Biologics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Biosimilars/Follow-on-Biologics Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Biosimilars/Follow-on-Biologics Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Biosimilars/Follow-on-Biologics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Biosimilars/Follow-on-Biologics: Market Segmentation 
FIG. 2 Global Biosimilars/Follow-on-Biologics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Biosimilars/Follow-on-Biologics Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Biosimilars/Follow-on-Biologics Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Biosimilars/Follow-on-Biologics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Biosimilars/Follow-on-Biologics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Biosimilars/Follow-on-Biologics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Biosimilars/Follow-on-Biologics Providers, 2019
FIG. 11 Global Biosimilars/Follow-on-Biologics Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Biosimilars/Follow-on-Biologics Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Biosimilars/Follow-on-Biologics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Biosimilars/Follow-on-Biologics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Biosimilars/Follow-on-Biologics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Biosimilars/Follow-on-Biologics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Biosimilars/Follow-on-Biologics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Biosimilars/Follow-on-Biologics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Biosimilars/Follow-on-Biologics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Biosimilars/Follow-on-Biologics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Biosimilars/Follow-on-Biologics Market Value, By Segment1, 2018 – 2028
TABLE  North America Biosimilars/Follow-on-Biologics Market Value, By Segment2, 2018 – 2028
TABLE  North America Biosimilars/Follow-on-Biologics Market Value, By Country, 2018 – 2028
TABLE  Europe Biosimilars/Follow-on-Biologics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Biosimilars/Follow-on-Biologics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Biosimilars/Follow-on-Biologics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Biosimilars/Follow-on-Biologics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Biosimilars/Follow-on-Biologics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Biosimilars/Follow-on-Biologics Market Value, By Country, 2018 – 2028
TABLE  Latin America Biosimilars/Follow-on-Biologics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Biosimilars/Follow-on-Biologics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Biosimilars/Follow-on-Biologics Market Value, By Country, 2018 – 2028
TABLE  MEA Biosimilars/Follow-on-Biologics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Biosimilars/Follow-on-Biologics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Biosimilars/Follow-on-Biologics Market Value, By Country, 2018 – 2028
TABLE  Novartis: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Genentech (Roche Group): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Synthon Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  LG Life Sciences: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Celltrion: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Teva Pharmaceutical Industries: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck Group: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biocon: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biogen idec, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hospira: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Biosimilars/Follow-on-Biologics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Biosimilars/Follow-on-Biologics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Biosimilars/Follow-on-Biologics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Biosimilars/Follow-on-Biologics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Biosimilars/Follow-on-Biologics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Biosimilars/Follow-on-Biologics Providers, 2016
FIG.  Global Biosimilars/Follow-on-Biologics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Human Growth Hormone Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Erythropoietin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Monoclonal Antibodies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Insulin Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Interferon Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Granulocyte-Colony Stimulating Factor Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Peptide Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Biosimilars/Follow-on-Biologics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Blood Disorders Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Oncology Diseases Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Chronic and Autoimmune Diseases Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Growth Hormone Deficiencies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Biosimilars/Follow-on-Biologics Market Value, 2018 – 2028, (US$ Mn)